Literature DB >> 32209358

Computational model predicts paracrine and intracellular drivers of fibroblast phenotype after myocardial infarction.

Angela C Zeigler1, Anders R Nelson2, Anirudha S Chandrabhatla1, Olga Brazhkina3, Jeffrey W Holmes4, Jeffrey J Saucerman5.   

Abstract

The fibroblast is a key mediator of wound healing in the heart and other organs, yet how it integrates multiple time-dependent paracrine signals to control extracellular matrix synthesis has been difficult to study in vivo. Here, we extended a computational model to simulate the dynamics of fibroblast signaling and fibrosis after myocardial infarction (MI) in response to time-dependent data for nine paracrine stimuli. This computational model was validated against dynamic collagen expression and collagen area fraction data from post-infarction rat hearts. The model predicted that while many features of the fibroblast phenotype at inflammatory or maturation phases of healing could be recapitulated by single static paracrine stimuli (interleukin-1 and angiotensin-II, respectively), mimicking the reparative phase required paired stimuli (e.g. TGFβ and endothelin-1). Virtual overexpression screens simulated with either static cytokine pairs or post-MI paracrine dynamic predicted phase-specific regulators of collagen expression. Several regulators increased (Smad3) or decreased (Smad7, protein kinase G) collagen expression specifically in the reparative phase. NADPH oxidase (NOX) overexpression sustained collagen expression from reparative to maturation phases, driven by TGFβ and endothelin positive feedback loops. Interleukin-1 overexpression had mixed effects, both enhancing collagen via the TGFβ positive feedback loop and suppressing collagen via NFκB and BAMBI (BMP and activin membrane-bound inhibitor) incoherent feed-forward loops. These model-based predictions reveal network mechanisms by which the dynamics of paracrine stimuli and interacting signaling pathways drive the progression of fibroblast phenotypes and fibrosis after myocardial infarction.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Year:  2020        PMID: 32209358      PMCID: PMC7434705          DOI: 10.1016/j.matbio.2020.03.007

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  105 in total

1.  Induction of cardiac fibroblast lysyl oxidase by TGF-β1 requires PI3K/Akt, Smad3, and MAPK signaling.

Authors:  Tetyana G Voloshenyuk; Elizabeth S Landesman; Elena Khoutorova; Andrew D Hart; Jason D Gardner
Journal:  Cytokine       Date:  2011-04-17       Impact factor: 3.861

2.  Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial.

Authors:  Paul M Ridker; Jean G MacFadyen; Brendan M Everett; Peter Libby; Tom Thuren; Robert J Glynn
Journal:  Lancet       Date:  2017-11-13       Impact factor: 79.321

3.  Increased interleukin-1β levels are associated with left ventricular hypertrophy and remodelling following acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention.

Authors:  S Ørn; T Ueland; C Manhenke; Ø Sandanger; K Godang; A Yndestad; T E Mollnes; K Dickstein; P Aukrust
Journal:  J Intern Med       Date:  2012-02-26       Impact factor: 8.989

4.  Time course of collagen and decorin changes in rat cardiac and skeletal muscle post-MI.

Authors:  S D Zimmerman; D P Thomas; S G Velleman; X Li; T R Hansen; R J McCormick
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-10       Impact factor: 4.733

5.  uPA, uPAR and TGFβ₁ expression during early and late post myocardial infarction period in rat myocardium.

Authors:  Anastasia Stavropoulou; Anastassios Philippou; Antonios Halapas; Antigone Sourla; Nikolaos Pissimissis; Michael Koutsilieris
Journal:  In Vivo       Date:  2010 Sep-Oct       Impact factor: 2.155

6.  Relation between myocardial beta-adrenoceptor density and hemodynamic and neurohumoral changes in a rat model of chronic myocardial infarction: effects of ibopamine and captopril.

Authors:  D J van Veldhuisen; O E Brodde; W H van Gilst; C Schulze; H Hegeman; R L Anthonio; E Scholtens; P A de Graeff; H Wesseling; K I Lie
Journal:  Cardiovasc Res       Date:  1995-09       Impact factor: 10.787

7.  Role of cardiac overexpression of ANG II in the regulation of cardiac function and remodeling postmyocardial infarction.

Authors:  Jiang Xu; Oscar A Carretero; Chun-Xia Lin; Maria A Cavasin; Edward G Shesely; James J Yang; Timothy L Reudelhuber; Xiao-Ping Yang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-06-22       Impact factor: 4.733

8.  Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling.

Authors:  K Ono; A Matsumori; T Shioi; Y Furukawa; S Sasayama
Journal:  Circulation       Date:  1998-07-14       Impact factor: 29.690

9.  Effects of timed administration of doxycycline or methylprednisolone on post-myocardial infarction inflammation and left ventricular remodeling in the rat heart.

Authors:  Ricardo A Garcia; Katrina V Go; Francisco J Villarreal
Journal:  Mol Cell Biochem       Date:  2006-12-06       Impact factor: 3.842

Review 10.  Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities.

Authors:  Sang-Bing Ong; Sauri Hernández-Reséndiz; Gustavo E Crespo-Avilan; Regina T Mukhametshina; Xiu-Yi Kwek; Hector A Cabrera-Fuentes; Derek J Hausenloy
Journal:  Pharmacol Ther       Date:  2018-01-09       Impact factor: 12.310

View more
  9 in total

1.  Cardiac fibroblast activation during myocardial infarction wound healing: Fibroblast polarization after MI.

Authors:  Michael J Daseke; Mavis A A Tenkorang; Upendra Chalise; Shelby R Konfrst; Merry L Lindsey
Journal:  Matrix Biol       Date:  2020-05-21       Impact factor: 11.583

Review 2.  Fibroblasts: The arbiters of extracellular matrix remodeling.

Authors:  Kristine Y DeLeon-Pennell; Thomas H Barker; Merry L Lindsey
Journal:  Matrix Biol       Date:  2020-06-03       Impact factor: 11.583

3.  Computational model of brain endothelial cell signaling pathways predicts therapeutic targets for cerebral pathologies.

Authors:  Catherine M Gorick; Jeffrey J Saucerman; Richard J Price
Journal:  J Mol Cell Cardiol       Date:  2021-11-16       Impact factor: 5.000

Review 4.  Properties and Functions of Fibroblasts and Myofibroblasts in Myocardial Infarction.

Authors:  Harikrishnan Venugopal; Anis Hanna; Claudio Humeres; Nikolaos G Frangogiannis
Journal:  Cells       Date:  2022-04-20       Impact factor: 7.666

Review 5.  Systems biology of angiogenesis signaling: Computational models and omics.

Authors:  Yu Zhang; Hanwen Wang; Rebeca Hannah M Oliveira; Chen Zhao; Aleksander S Popel
Journal:  WIREs Mech Dis       Date:  2021-12-30

6.  Network model-based screen for FDA-approved drugs affecting cardiac fibrosis.

Authors:  Angela C Zeigler; Anirudha S Chandrabhatla; Steven L Christiansen; Anders R Nelson; Jeffrey W Holmes; Jeffrey J Saucerman
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-02-27

7.  Network modeling predicts personalized gene expression and drug responses in valve myofibroblasts cultured with patient sera.

Authors:  Jesse D Rogers; Brian A Aguado; Kelsey M Watts; Kristi S Anseth; William J Richardson
Journal:  Proc Natl Acad Sci U S A       Date:  2022-02-22       Impact factor: 12.779

8.  Fibroblast mechanotransduction network predicts targets for mechano-adaptive infarct therapies.

Authors:  Jesse D Rogers; William J Richardson
Journal:  Elife       Date:  2022-02-09       Impact factor: 8.140

9.  The Cell Surface Receptors Ror1/2 Control Cardiac Myofibroblast Differentiation.

Authors:  Nicholas W Chavkin; Soichi Sano; Ying Wang; Kosei Oshima; Hayato Ogawa; Keita Horitani; Miho Sano; Susan MacLauchlan; Anders Nelson; Karishma Setia; Tanvi Vippa; Yosuke Watanabe; Jeffrey J Saucerman; Karen K Hirschi; Noyan Gokce; Kenneth Walsh
Journal:  J Am Heart Assoc       Date:  2021-06-22       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.